Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273884
Status:
COMPLETED
Last Update Posted:
2007-02-19
First Post:
2006-01-05
Brief Title:
Amonafide in Combination With Cytarabine in Secondary AML
Sponsor:
Xanthus Pharmaceuticals Inc
Organization:
Xanthus Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2009-04
Completion Date Type:
None
First Submit Date:
2006-01-05
First Submit QC Date:
January 5 2006
Study First Post Date:
2006-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-02-16
Last Update Post Date:
2007-02-19
Last Update Post Date Type:
ESTIMATED